The mammalian respiratory tract is densely innervated by autonomic and sensory nerves around airways and blood vessels. Subsets of these nerves contain a number of putative neurotransmitter peptides, such as substance P and calcitonin gene-related peptide (CGRP) in sensory nerves and vasoactive intestinal polypeptide (VIP), possibly serving autonomic functions. CGRP is also found in endocrine cells in rat airway epithelium. These peptides are all pharmacologically potent effectors of bronchial and vascular smooth muscle and bronchial secretion. Their functions in vivo are less well established. We have therefore examined the effects of inhaled acrolein, a sensory irritant, on three pulmonary neuropeptides: CGRP, substance P, and VIEP. Groups of rats (n = 3 each) were exposed for 10 min to acrolein in air (Ct = 510, 1858, and 5693 mg.min/m3) or to air alone. Fifteen minutes later they were killed (pentabarbitone IP) and their respiratory tracts were dissected and fixed in 0.4 % p-benzoquinone solution. Cryostat sections were stained by indirect immunofluorescence for a general nerve marker (PGP 9.5) and neuropeptides. The acrolein-treated animals had a dose-related decrease in tracheal substance P-and CGRP-immunoreactive nerve fibers compared with controls. No change was seen in total nerve flber distribution and number (PGP 9.5) or VIP immunoreactivity, nor in CGRP-immunoreactive epithelial endocrine cells. It is concluded that the rat tracheal peptidergic nerves are a sensitive indicator of inhaled irritant substances. Their reduced immunoreactivity may be because of a release of sensory neuropeptides that could play a role in the physiological response to irritant or toxic compounds.
Introduction
The respiratory tract is densely innervated by sensory and automatic fibers (1) that together with endocrine cells in the epithelium of airways form the socalled diffuse neuroendocrine system. Subsets of both the nerves and endocrine cells are known to contain bioactive regulatory peptides that can act locally as hormones or possibly as neurotransmitters/modulators (2) . The neuropeptides include substance P (3) and other tachykinins (4); calcitonin gene-related peptide (CGRP), also found in endocrine cells (5) ; vasoactive intestinal polypeptide (VIP) (6); peptide histidine isoleucine or methionine (PHI/M) (7); galanin (8) ; and neuropeptide tyrosine (NPY) (9, 10) . These peptides have strong actions on vascular and airway smooth muscle and glandular secretion (11, 12) . The distribution of nerves containing the different peptides may be analyzed by examining tissue sections immunostained with specific antisera to each peptide (2) .
Of the neuropeptides in the respiratory tract, two are known to be predominantly in the sensory nervous system. These are CGRP and substance P. This sensory system is known to respond to inhaled irritants such as cigarette smoke (13) , resulting in a release of neuropeptides and thus decreasing the peptide immunoreactivity of the fibers. Such local release of substance P following nerve stimulation has been observed (12, 14) and shown to cause local vasodilatation and plasma extravazation (13) .
Acrolein is an unsaturated aliphatic aldehyde with toxic and sensory irritating effects (15) (16) (17) (18) (19) . It is a component of cigarette smoke (20) , engine exhausts (21) , and industrial by-products (22) . We have, therefore, examined by immunocytochemical techniques the effect of acute exposure to acrolein vapor in the rat. The aim was to Fifteen minutes after termination of exposure the animals were killed by pentobarbitone overdose injected IP. The thorax was opened, the respiratory tract dissected out, and specimens were taken from upper and lower trachea and lung (a 3-mm thick slice at the hilar level of right lower and left lobes). The tissues were immediately fixed by immersion for 2 hr in 0.4% solution of p-benzoquinone in phosphate-buffered saline (PBS) (0.01 mole/L phosphate buffer, pH 7.4, containing 0.15 mole/L NaCl), then washed and stored at 40C in PBS containing 0.15 mole/L sucrose and 0.01% sodium azide.
Cryostat blocks were prepared and frozen sections (7 ,um thick) taken up on poly-L-lysine-coated slides. From each block, one section was stained by hematoxylin and eosin for morphological examination, and 10 sections were immunostained for each antiserum. Antisera to the general neuronal marker PGP 9.5 (23) and the neuropeptides CGRP, substance P, and VIP were used with a modified indirect immunofluorescence method (5 E z epithelium, mucosa, smooth muscle and blood vessels of the trachea (Fig. 4) , and around airways and blood vessels in the lung (Fig. 5) . Scattered fibers were also seen in the lung parenchyma and endocrine cells in the airway epithelium.
CGRP and Substance P These two neuropeptides are considered together because they had similar distributions and responses to acrolein. Immunoreactive fibers (Figs. 6-8) were seen in and below airway epithelium, in smooth muscle bundles and surrounding blood vessels, and in a proportion of the fibers in nerve bundles in the tracheal adventitia. The number of CGRP-immunoreactive fibers was somewhat greater than those that have substance P staining. The acrolein-treated animals showed a progressive dosedependent decrease in the number of nerves immunoreactive for either peptide but most markedly substance P (Figs. 1-3, 6-8) , and the effect spread further down the respiratory tract with increasing doses. Thus, the low dose (Ct = 510 mg.min/m3) caused little change in CGRP-immunoreactive nerves with a noticeable decrease in those immunoreactive for substance P in the trachea (Fig. 7) , particularly the fibers near the epithelium. The moderate dose (Ct = 1858 mg.min/m3) caused a greater depletion of CGRP and substance P immunoreactivity and only a few fibers were stainable in the high dose (Ct = 5693 mg.min/m3) group (Fig. 7) . In the lung, changes were seen only in animals receiving the high dose of acrolein, and the depletion was more markedly seen in the substance P-immunoreactive fibers (Figs. 6  and 8 ). No obvious changes were detected in numbers of epithelial endocrine cells immunoreactive for CGRP.
VIP
Immunoreactive nerve fibers were seen principally in vascular and airway smooth muscle and around glands in the trachea. No change was seen in their numbers in the acrolein-treated animals compared with controls (data not shown).
Discussion
This study has shown that acute treatment with acrolein results in a decrease in the number of nerves immunoreactive for regulatory peptides. Also, it shows that this response is dose related.
Acrolein is a sensory irritant compound, and it is therefore relevant that the two peptides showing changes are substance P and CGRP; these are the two main neuropeptides in the sensory innervation of rodent respiratory tract (24, 25) . This suggests that the acute exposure to acrolein affects only the sensory nerves and not the autonomic fibers, at least not those containing VIP (mainly postganglionic parasympathetic). It also confirms that acrolein is a sensory irritant. No obvious changes in CGRP-immunoreactive endocrine cells were seen, but a full quantitative study was not undertaken. There is only a slight decrease in nerve fibers stained in the treated group; compare with substance P in lung (Fig. 8 ). x 320.
FIGURE 7. Substance P-immunoreactive nerve fibers in rat trachea.
The number of nerves (arrows) in epithelium (E) decrease from the control animals (a), to the low dose acrolein treatment (b), and are almost absent from the high-dose treated animals (c). The diffuse staining below the epithelium in (c) is due to autofluorescence of collagen fibers. x320. (14) . This has been shown to occur with other sensory irritants such as cigarette smoke both for substance P (13) and for CGRP, both by immunocytochemistry and radioimmunoassay (unpublished observation).
The apparent greater sensitivity of substance P-immunoreactive nerves is interesting, Substance P and CGRP are known to be co-localized in some sensory nerves (12, 27) , but in the rat there are more CGRP-than substance P-immunoreactive nerve cell bodies in ganglia innervating the respiratory tract (25) . Thus, it is possible that some sensory nerves contain CGRP alone. Where there is co-localization, the peptides are both found in the same secretory granule (27) and therefore must be co-released, which permits CGRP to potentiate the actions of substance P (28). It is possible, therefore, that this type of nerve is more sensitive to acrolein and releases its stored peptides at lower levels of stimulation than those containing CGRP alone, resulting in an apparently greater decrease of immunoreactive substance P nerves than CGRP nerves. Whatever is the case, substance P appears to be a more sensitive indicator of neural response to sensory irritants than is CGRP. This conclusion is amplified by the observation of a decrease in substance P immunoreactivity in the lung at the high dose level of acrolein, whereas CGRP was little affected. The effects of sensory irritation were less marked in the lung than the trachea, probably because of the high aqueous solubility of acrolein resulting in absorption of most of the vapor in the upper respiratory tract (29) . It is therefore probable that had the nasal mucosa been studied here, decreases in sensory peptides would have been detected at lower acrolein concentrations than in the trachea.
The concentrations of acrolein used in this study are high (22, 81 , and 249 ppm), compared with the RD50 concentration of 1.7 ppm (26) . It would be interesting to determine whether the use of lower concentrations for a longer time to give equivalent doses would have similar effects on peptidergic nerves. In rats exposed to cigarette smoke, the effects on neuropeptides of a single exposure are reduced if the animals have been acclimatized to smoke (unpublished observations).
In conclusion, this study has demonstrated that acute acrolein exposure causes a marked, dose-related depletion of sensory neuropeptides in the rat lower respiratory tract. Evidence suggests that this is due to release of CGRP and substance P from nerve terminals; these released peptides could be involved in the response to acrolein by causing vasodilatation and bronchoconstriction. Thus, it is proposed that investigation of changes in sensory neuropeptides in trachea may be a sensitive indicator of the response to sensory irritants.
